Dr Mark Jacob Eichler, MD | |
505 Ne 87th Ave, Bldg B, Suite 301, Vancouver, WA 98664-1989 | |
(360) 514-7374 | |
(360) 514-7384 |
Full Name | Dr Mark Jacob Eichler |
---|---|
Gender | Male |
Speciality | General Surgery |
Experience | 18 Years |
Location | 505 Ne 87th Ave, Vancouver, Washington |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1285832956 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208600000X | Surgery | MD157519 (Oregon) | Secondary |
208600000X | Surgery | MD60337677 (Washington) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Peacehealth Southwest Medical Center | Vancouver, WA | Hospital |
Peacehealth St John Medical Center | Longview, WA | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Peacehealth | 5890689293 | 182 |
Peacehealth | 8820178288 | 169 |
News Archive
Rexahn Pharmaceuticals, Inc., a clinical stage biopharmaceutical company announced today initial data for the Phase I dose-escalation clinical trial of SupinoxinTM (RX-5902) initiated in August 2013. This trial was designed to study safety and efficacy in patients with solid cancer tumors.
The American Civil Liberties Union and the Public Patent Foundation at Benjamin N. Cardozo School of Law (PUBPAT) filed a lawsuit today charging that patents on two human genes associated with breast and ovarian cancer stifle research that could lead to cures and limit women's options regarding their medical care.
The COVID-19 pandemic has had a profound effect on higher education - shifting classes online, canceling events, and putting financial strain on institutions.
ALPHAEON Corporation, a subsidiary of Strathspey Crown Holdings LLC, and Zelegent, Inc. jointly announced today that the two companies have entered into an exclusive worldwide agreement to bring Zelegent's office-based Elevoplasty technology to board certified sleep specialists.
› Verified 5 days ago
Entity Name | Peacehealth |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1720056187 PECOS PAC ID: 5890689293 Enrollment ID: O20040209000272 |
News Archive
Rexahn Pharmaceuticals, Inc., a clinical stage biopharmaceutical company announced today initial data for the Phase I dose-escalation clinical trial of SupinoxinTM (RX-5902) initiated in August 2013. This trial was designed to study safety and efficacy in patients with solid cancer tumors.
The American Civil Liberties Union and the Public Patent Foundation at Benjamin N. Cardozo School of Law (PUBPAT) filed a lawsuit today charging that patents on two human genes associated with breast and ovarian cancer stifle research that could lead to cures and limit women's options regarding their medical care.
The COVID-19 pandemic has had a profound effect on higher education - shifting classes online, canceling events, and putting financial strain on institutions.
ALPHAEON Corporation, a subsidiary of Strathspey Crown Holdings LLC, and Zelegent, Inc. jointly announced today that the two companies have entered into an exclusive worldwide agreement to bring Zelegent's office-based Elevoplasty technology to board certified sleep specialists.
› Verified 5 days ago
Entity Name | Peacehealth |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1609061969 PECOS PAC ID: 8820178288 Enrollment ID: O20080110000429 |
News Archive
Rexahn Pharmaceuticals, Inc., a clinical stage biopharmaceutical company announced today initial data for the Phase I dose-escalation clinical trial of SupinoxinTM (RX-5902) initiated in August 2013. This trial was designed to study safety and efficacy in patients with solid cancer tumors.
The American Civil Liberties Union and the Public Patent Foundation at Benjamin N. Cardozo School of Law (PUBPAT) filed a lawsuit today charging that patents on two human genes associated with breast and ovarian cancer stifle research that could lead to cures and limit women's options regarding their medical care.
The COVID-19 pandemic has had a profound effect on higher education - shifting classes online, canceling events, and putting financial strain on institutions.
ALPHAEON Corporation, a subsidiary of Strathspey Crown Holdings LLC, and Zelegent, Inc. jointly announced today that the two companies have entered into an exclusive worldwide agreement to bring Zelegent's office-based Elevoplasty technology to board certified sleep specialists.
› Verified 5 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Mark Jacob Eichler, MD 505 Ne 87th Ave, Bldg B, Suite 301, Vancouver, WA 98664-1989 Ph: (360) 514-7374 | Dr Mark Jacob Eichler, MD 505 Ne 87th Ave, Bldg B, Suite 301, Vancouver, WA 98664-1989 Ph: (360) 514-7374 |
News Archive
Rexahn Pharmaceuticals, Inc., a clinical stage biopharmaceutical company announced today initial data for the Phase I dose-escalation clinical trial of SupinoxinTM (RX-5902) initiated in August 2013. This trial was designed to study safety and efficacy in patients with solid cancer tumors.
The American Civil Liberties Union and the Public Patent Foundation at Benjamin N. Cardozo School of Law (PUBPAT) filed a lawsuit today charging that patents on two human genes associated with breast and ovarian cancer stifle research that could lead to cures and limit women's options regarding their medical care.
The COVID-19 pandemic has had a profound effect on higher education - shifting classes online, canceling events, and putting financial strain on institutions.
ALPHAEON Corporation, a subsidiary of Strathspey Crown Holdings LLC, and Zelegent, Inc. jointly announced today that the two companies have entered into an exclusive worldwide agreement to bring Zelegent's office-based Elevoplasty technology to board certified sleep specialists.
› Verified 5 days ago
Andrew Edward Glover, DO Surgery Medicare: Accepting Medicare Assignments Practice Location: 700 Ne 87th Ave, Vancouver, WA 98664 Phone: 360-397-3936 | |
Louis Moreau, MD Surgery Medicare: Not Enrolled in Medicare Practice Location: 700 Ne 87th Ave, Vancouver, WA 98664 Phone: 360-397-1500 Fax: 360-604-1771 | |
Michael John O'toole, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 2211 E Mill Plain Blvd, Vancouver, WA 98661 Phone: 360-619-4244 | |
Toni Lucille Storm, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 210 Se 136th Ave, Vancouver, WA 98684 Phone: 360-944-9889 Fax: 360-944-9686 | |
Jane Namkung, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 13712 Ne 10th Ave, Vancouver, WA 98685 Phone: 360-823-0860 | |
Dr. James Bernard Kilway Ii, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 8614 E Mill Plain Blvd, Suite #201, Vancouver, WA 98664 Phone: 360-254-9991 Fax: 360-254-9997 | |
Dr. Kathleen Alison Dunham, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 1498 Se Tech Center Pl, Suite 240, Vancouver, WA 98683 Phone: 360-597-1300 |